About Intuitive Surgical Inc
Ticker
info
ISRG
Trading on
info
NASDAQ
ISIN
info
US46120E6023
Industry
info
Medical Instruments & Supplies
Sector
info
Healthcare
CEO
info
David J. Rosa
Headquarters
info
1020 Kifer Road, Sunnyvale, CA, United States, 94086-5304
Employees
info
15,638
Website
info
intuitive.com
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Metrics
BasicAdvanced
Market cap
info
$199B
P/E ratio
info
74.07
EPS
info
$7.56
Dividend Yield
info
0.00%
Beta
info
1.69
Forward P/E ratio
info
47.85
EBIDTA
info
$3.41B
Ex dividend date
info
-
Price & volume
Market cap
info
$199B
Average daily volume
info
2.7M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
74.07
Forward P/E
info
47.85
PEG ratio
info
2.79
Trailing P/E
info
74.07
Price to sales
info
20.65
Price to book
info
8.9
Earnings
EPS
info
$7.56
EPS estimate (current quarter)
info
$1.99
EPS estimate (next quarter)
info
$2.18
EBITDA
info
$3.41B
Revenues (TTM)
info
$9.61B
Revenues per share (TTM)
info
$26.91
Technicals
Beta
info
1.69
52-week High
info
$616.00
52-week Low
info
$425.00
50-day moving average
info
$471.89
200-day moving average
info
$510.73
Short ratio
info
3.13
Short %
info
2.09%
Management effectiveness
ROE (TTM)
info
16.90%
ROA (TTM)
info
9.56%
Profit margin
info
28.58%
Gross profit margin
info
$6.38B
Operating margin
info
30.33%
Growth
Quarterly earnings growth (YoY)
info
25.00%
Quarterly revenue growth (YoY)
info
22.90%
Share stats
Outstanding Shares
info
354M
Float
info
352M
Insiders %
info
0.53%
Institutions %
info
87.92%
Analyst Insights & forecasts
info

67% Buy

30% Hold

3% Sell

Based on information from 33 analysts.

Average price target

info
$592.96
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$2.21
$1.79
23.46%
Q4 • 24Beat
$1.81
$1.73
4.62%
Q1 • 25Beat
$2.19
$1.92
14.06%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$2.44B
$658M
26.98%
Q2 • 25
$2.51B
$704M
28.12%
Q3 • 25
2.67%
6.99%
4.21%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$20.2B
$2.21B
10.96%
Q2 • 25
$19.4B
$2.31B
11.94%
Q3 • 25
-4.02%
4.51%
8.89%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$715M
$261M
$-148M
$560M
Q2 • 25
$841M
-
$-1.84B
$736M
Q3 • 25
17.56%
-
1,146.96%
31.33%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Intuitive Surgical Inc share?
Collapse

Intuitive Surgical Inc shares are currently traded for undefined per share.

How many shares does Intuitive Surgical Inc have?
Collapse

Intuitive Surgical Inc currently has 354M shares.

Does Intuitive Surgical Inc pay dividends?
Collapse

No, Intuitive Surgical Inc doesn't pay dividends.

What is Intuitive Surgical Inc 52 week high?
Collapse

Intuitive Surgical Inc 52 week high is $616.00.

What is Intuitive Surgical Inc 52 week low?
Collapse

Intuitive Surgical Inc 52 week low is $425.00.

What is the 200-day moving average of Intuitive Surgical Inc?
Collapse

Intuitive Surgical Inc 200-day moving average is $510.73.

Who is Intuitive Surgical Inc CEO?
Collapse

The CEO of Intuitive Surgical Inc is David J. Rosa.

How many employees Intuitive Surgical Inc has?
Collapse

Intuitive Surgical Inc has 15,638 employees.

What is the market cap of Intuitive Surgical Inc?
Collapse

The market cap of Intuitive Surgical Inc is $199B.

What is the P/E of Intuitive Surgical Inc?
Collapse

The current P/E of Intuitive Surgical Inc is 74.07.

What is the EPS of Intuitive Surgical Inc?
Collapse

The EPS of Intuitive Surgical Inc is $7.56.

What is the PEG Ratio of Intuitive Surgical Inc?
Collapse

The PEG Ratio of Intuitive Surgical Inc is 2.79.

What do analysts say about Intuitive Surgical Inc?
Collapse

According to the analysts Intuitive Surgical Inc is considered a buy.